These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7573116)

  • 41. Autoantibodies against insulin and beta-islet cells in pancreatic adenocarcinoma: a possible explanation for diabetes mellitus.
    Syrigos KN; Konstantoulakis MM; Fyssas I; Katsilambros N; Golematis BC
    Int J Cancer; 1996 May; 66(5):624-6. PubMed ID: 8647623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-insulin activity in normal newborn cord-blood serum: absence of IgG-mediated insulin binding.
    Bilbao JR; Calvo B; Urrutia I; Linares A; Castaño L
    Diabetes; 1997 Apr; 46(4):713-6. PubMed ID: 9075816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between insulin autoantibodies and islet cell histology in the diabetes prone BB rat.
    Diaz JL; Daneman D; Martin JM; Sochett E; Wilkin TJ
    Autoimmunity; 1991; 11(1):45-51. PubMed ID: 1812995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old.
    Berger B; Borg H; Fernlund P; Stenström G; Sundkvist G
    Diabet Med; 2006 Nov; 23(11):1180-5. PubMed ID: 17054592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests].
    Lazar D; Weintrob N; Abramov N; Assa S; Bloch K; Ofan R; Ben-Zaken H; Vardi P
    Harefuah; 1998 May; 134(9):678-81, 750. PubMed ID: 10909610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus.
    Turner RC; Holman RR
    Diabetes; 1978; 27 Suppl 1():241-6. PubMed ID: 344115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice.
    Robles DT; Eisenbarth GS; Dailey NJ; Peterson LB; Wicker LS
    Diabetes; 2003 Mar; 52(3):882-6. PubMed ID: 12606534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
    Yang L; Zhou ZG; Huang G; Yan X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
    Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
    J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Islet function in diabetics with persistent islet cell antibodies.
    Theophanides CG; Pyke DA; Watkins PJ
    Diabetes; 1978; 27 Suppl 1():265-6. PubMed ID: 344118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.
    Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes.
    Pugliese A; Bugawan T; Moromisato R; Awdeh ZL; Alper CA; Jackson RA; Erlich HA; Eisenbarth GS
    J Clin Invest; 1994 Jun; 93(6):2447-52. PubMed ID: 8200980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [LADA--latent autoimmune diabetes in adults].
    Szelachowska M
    Endokrynol Pol; 2007; 58(3):246-51. PubMed ID: 17940991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Improved radioligand assay of insulin autoantibody].
    Wang JP; Zhou ZG; Huang G; Deng ZM; Li X; Peng J; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):414-8. PubMed ID: 16134593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancreatic alpha-cell function in diabetic hemochromatotic subjects.
    Nelson RL; Baldus WP; Rubenstein AH; Go VL; Service FJ
    J Clin Endocrinol Metab; 1979 Sep; 49(3):412-6. PubMed ID: 381322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secretin, glucagon, insulin-antibodies, islet-cell exhaustion and diabetes mellitus : a hypothesis.
    Malhotra SL
    Med Hypotheses; 1982 Jan; 8(1):105-10. PubMed ID: 7038409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus.
    Yue DK; Baxter RC; Turtle JR
    Metabolism; 1978 Jan; 27(1):35-44. PubMed ID: 619224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exacerbation of diabetes mellitus by antibodies to exogenous insulin.
    Rendell M; Hamilton RG; Drew HM; Adkinson NF
    Am J Med Sci; 1981; 282(1):18-26. PubMed ID: 7270568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.